For Medical and Pharmacy,CNS basic and clinical Pharmacology

Explore major central nervous system diseases—insomnia, anxiety, epilepsy, depression, schizophrenia, Parkinson's, and Alzheimer's—through their causes, symptoms, and pharmacological treatments, including GABA, dopamine, norepinephrine, serotonin mechanisms and medicinal chemistry.

Explore the central nervous system, brain and spinal cord, and autonomic and somatic branches, and how GABA/glycine inhibit while glutamate/aspartate excite through NMDA and ion channels.

Explore insomnia management with non pharmacological approaches like exercise, acupuncture, and yoga, and pharmacological options including antihistamines, doxepin, benzodiazepines, zolpidem, zaleplon, melatonin agonists, and melatonin preparations to reset circadian cycles.

Explore anxiety disorders, including obsessive-compulsive disorder and phobias, and how benzodiazepines and propranolol help alleviate panic and associated symptoms.

Epilepsy is a neurological condition with partial and generalized seizures, including simple and complex partial, absence, and tonic-clonic types, managed with various anti-epileptic drugs.

Explore depression, its two-week symptom criteria, major depressive disorder and bipolar depression with manic episodes. Learn norepinephrine and serotonin roles and treatments, including TCAs, MAO inhibitors, SSRIs, SNRIs, and lithium.

Explore schizophrenia as a psychosis with positive and negative symptoms and cognitive impairment from dopamine imbalance and genetics, and compare typical and atypical antipsychotics and their hit-and-run dynamics.

Parkinsonism is explained as an imbalance of dopamine and acetylcholine in the extrapyramidal system and corpus striatum, causing stiffness, bradykinesia, and tremor.

Alzheimer's disease involves amyloid plaques and tau tangles that damage neurons, shrink the brain, and cause memory loss and dementia; treatments include acetylcholinesterase inhibitors, memantine, and antidepressants.

Explore the major CNS medicinal chemistry structures, focusing on benzodiazepines and barbiturates, their ring systems, receptor targets, and acting profiles, plus an overview of typical and atypical antipsychotics.